Strategic Financing in the Life Sciences
Image
Pace
Instructor-led
Subject
Difficulty
- Advanced
Credit
Certificate of Completion
Platform
Harvard Business School Executive Education
What you'll learn
Evaluate financing options specific to the life sciences industry, including the pharmaceutical, biotechnology, and medtech sectors
Make financing decisions in the context of drug development phase, cash runway requirements, repayment obligations, potential need for future financing rounds, product risk profile, and other factors
Structure venture capital rounds and prepare for IPOs while balancing dilution concerns with capital needs
Assess the benefits of royalty monetization transactions for pipeline assets
Balance upfront capital needs with long-term value retention
Negotiate strategic partnerships and licensing agreements that provide non-dilutive capital while maintaining flexibility
Course description
As the pharmaceutical, biotechnology, and medtech (medical devices and diagnostics) industries have grown, so has the complexity of financing options. Today's most successful executives move their company ahead with the help of an in-depth understanding of how financing intersects with strategy, portfolio management, business development, mergers and acquisitions, and long-term value creation.
Strategic Financing in the Life Sciences brings together accomplished executives to develop a finance-driven lens for decision-making. You'll gain insight into the spectrum of innovative financing strategies available to pharmaceutical, biotechnology, and medtech companies at different stages of development. Empowered with frameworks for evaluating different financing options, you can confidently map your financing strategy to your corporate objectives and pipeline development.
You may also like
